Position in MYGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$469,656
-$1,040,279 QoQ
Shares Held
104,368
-63.3% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026XTX Topco Ltd holds $41,083,084 across 30 Diagnostics & Research names. MYGN ranks #23 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
48,954 | $9,281,678 | |
| 2 | QGEN |
Qiagen N.V.
|
139,964 | $5,604,158 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
4,485 | $2,520,076 | |
| 4 | A |
Agilent Technologies, Inc.
|
21,899 | $2,496,048 | |
| 5 | ILMN |
Illumina, Inc.
|
15,786 | $1,945,782 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
3,716 | $1,784,386 | |
| 7 | LH |
Labcorp Holdings Inc.
|
6,546 | $1,746,538 | |
| 8 | FLGT |
Fulgent Genetics, Inc.
|
92,499 | $1,470,734 |
All Filings in MYGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $469,656 | 104,368 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $1,509,935 | 284,357 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $188,132 | 21,210 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $878,536 | 64,080 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $305,590 | 11,157 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $306,410 | 12,527 | Shares | Defined | 2024-08-12 | |
| 2023-06-30 | $227,743 | 9,825 | Shares | Defined | 2023-08-14 | |
| 2021-03-31 | $303,708 | 9,974 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||